Fast Market Research

New Report Available: Acorda Therapeutics, Inc. - Product Pipeline Review - 2013

Fast Market Research recommends "Acorda Therapeutics, Inc. - Product Pipeline Review - 2013" from Global Markets Direct, now available

 
Repost This

Boston, MA -- (SBWIRE) -- 02/06/2014 -- Global Market Direct's pharmaceuticals report, "Acorda Therapeutics, Inc. - Product Pipeline Review - 2013" provides data on the Acorda Therapeutics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Acorda Therapeutics, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Acorda Therapeutics, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Acorda Therapeutics, Inc. - Brief Acorda Therapeutics, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Acorda Therapeutics, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Acorda Therapeutics, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Acorda Therapeutics, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Acorda Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Acorda Therapeutics, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Acorda Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Acorda Therapeutics, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Acorda Therapeutics, Inc. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Acorda Therapeutics, Inc.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Lymphoma - Pipeline Review, H2 2013
- Nektar Therapeutics - Product Pipeline Review - 2013
- Addex Therapeutics - Product Pipeline Review - 2013
- Cell Therapeutics, Inc. - Product Pipeline Review - 2013
- Amicus Therapeutics, Inc. - Product Pipeline Review - 2013
- United Therapeutics Corporation - Product Pipeline Review - 2013
- Stemline Therapeutics, Inc. - Product Pipeline Review - 2013
- e-Therapeutics plc - Product Pipeline Review - 2013
- TG Therapeutics, Inc. - Product Pipeline Review - 2013
- Chronos Therapeutics Limited - Product Pipeline Review - 2013